Peptidal
CJC-1295 Without DAC 5mg + Ipamorelin 5mg Bundle
CJC-1295 Without DAC 5mg + Ipamorelin 5mg Bundle
Couldn't load pickup availability
Growth Hormone Bundle Overview
This synergistic research bundle combines CJC-1295 without DAC and Ipamorelin in a single convenient vial. This powerful combination provides researchers with complementary growth hormone releasing mechanisms, offering both GHRH analogue activity and selective GHRP action in one optimised formulation.
Combined Formulation Specifications
- CJC-1295 without DAC Content: 5mg per vial
- Ipamorelin Content: 5mg per vial
- Total Peptide Content: 10mg per vial
- Formulation: Lyophilised powder blend
- Purity: ≥98% combined (HPLC verified)
- Appearance: White lyophilised powder
Individual Component Properties
CJC-1295 without DAC: C152H252N44O42 (3367.97 Da) - Modified GHRH with enhanced stability
Ipamorelin: C38H49N9O5 (711.85 Da) - Selective pentapeptide GHRP with high receptor specificity
Synergistic Research Applications
This combined formulation is utilised in research contexts investigating:
- Dual-pathway growth hormone release mechanisms
- GHRH and GHRP receptor interaction studies
- Synergistic pituitary gland stimulation research
- Combined growth hormone secretagogue efficacy analysis
- Simplified dosing protocol investigations
- Complementary growth hormone regulation pathways
Bundle Contents
- 1 x Mixed peptide vial containing CJC-1295 without DAC (5mg) + Ipamorelin (5mg)
- Certificate of Analysis for the combined formulation
- Comprehensive handling and reconstitution guidelines
- Synergistic research protocol recommendations
- Growth hormone release timing guidelines
Storage & Handling
- Storage Temperature: -20°C (lyophilised), 2-8°C (reconstituted, short-term)
- Stability: 24 months lyophilised, 30 days reconstituted at 2-8°C
- Reconstitution: Use sterile water or bacteriostatic water
- Handling: Single vial convenience, avoid repeated freeze-thaw cycles
Quality Assurance
The combined formulation undergoes comprehensive analytical testing including HPLC purity analysis for both components, mass spectrometry verification, amino acid analysis, and endotoxin testing. Certificate of Analysis provided for the complete mixed formulation.
For research purposes only. Not for human consumption or therapeutic use.
Share
